austlii:cth/ARTA/2025/638
General information, not legal advice.
ARTA
2025-05-23
Original judgment source is linked above.
(a) The applicant; > > (b) Dr Sethi, a consultant gastroenterologist and hepatologist.
(a) Does the applicant suffer from an 'ailment' or an 'aggravation' of an ailment? If so, > > (b) Is the ailment or aggravation of such ailment a 'disease'? > > (c) If the ailment or aggravation of such ailment is a disease, was it contributed to, to a significant degree, by the applicant's employment by the Commonwealth?
(a) The applicant's IBS is constitutional; > > (b) The length of time between deployment in Afghanistan and the onset of IBS means that events during the applicant's deployment, including hygiene conditions and contaminated water did not play any causative role; > > (c) A causative link between PTSD and IBS has never been established in the clinical trials; > > (d) Dr Sethi disagrees with the opinion of Dr Corbett, that the applicant's IBS was caused by infection, and notes Dr Corbett's view is 'at odds with widespread medical and scientific thinking'; > > (e) Dr Sethi disagrees with the opinion of Dr Ryan, that the applicant's IBS was most likely related to his PTSD.
(a) History taking; > > (b) Physical examination; > > (c) Clinical synthesis; and > > (d) Review of documentation.
(a) It is usually caused by visceral hypersensitivity of the gastrointestinal tract. This means the gut starts to send signals to the brain when it should be ignoring them. Those signals are painful. > > (b) Dysmotility of the bowel. > > (c) Increased body weight or obesity. > > (d) Smoking can be a contributing factor. > > (e) It tends to be more prevalent in women.
Introduction, some observations concerning the witnesses who gave oral evidence
Another possible contributing factor to the applicant's IBS
Inflammation from infections causing IBS (postinfectious IBS) and possible treatment
Visceral hypersensitivity of the applicant's gastrointestinal tract
Did the applicant's PTSD or stress aggravate his IBS condition?
[2] The letter of instruction to Dr Sethi dated 19 May 2023 and attached documentation comprised a further 346 pages.
[14] Dudzinska, Grabrucker, Kwiatowski, Sitarz and Sienkiewicz, "The importance of Visceral Hypersensitivity in Irritable Bowel Syndrome-Plant Metabolites in IBS Treatment." Pharmaceuticals (Basel); 16 (10).
[15] Deiteren, de Wit, van der Linder, De Man, Pelckmans, De Winter, "Irritable Bowel Syndrome and Visceral Hypersensitivity: Risk Factors and Patho-physiological Mechanisms." Acta Gastro-Enterologica Belgica, Vol LXXIX.
[16] The articles are in Tabs A1 to A9 JTB.
[17] Dr Corbett JTB 258 and Dr Sethi JTB 276.
[18] In addition to his evidence on this topic when in the witness box this contention was recorded in paragraph 4 of his report of 31 May 2023. (JTB 278).
[32] JTB 116, American Journal of Gastroenterology, Vol 1, Issue 1, July 2012, Collins, Chang and Mearin, "Postinfectious Chronic Gut Dysfunction: From Bench to Bedside".
[33] Makita (Australia) Pty Ltd v Sprowles [2001] NSWCA 305; (2001) 52 NSWLR 705.
[34] Arnotts Ltd & Ors v Trade Practices Commission (1990) 97 ALR 555 at 590.
[35] [2006] AATA 506 at [26].
Arnotts Ltd & Ors
Trade Practices Commission
Robinson and Military Rehabilitation and Compensation Commission [2006] AATA 506
(2001) 52 NSWLR 705
(1990) 97 ALR 555